Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.540
-0.010 (-0.65%)
At close: Aug 6, 2025, 4:00 PM
1.560
+0.020 (1.30%)
After-hours: Aug 6, 2025, 4:10 PM EDT
Company Description
Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products.
It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.
Cibus, Inc.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jul 20, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 159 |
| CEO | Peter Beetham |
Contact Details
Address: 6455 Nancy Ridge Drive San Diego, California 92121 United States | |
| Phone | 858 450 0008 |
| Website | cibus.com |
Stock Details
| Ticker Symbol | CBUS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001705843 |
| CUSIP Number | 17166A101 |
| ISIN Number | US17166A1016 |
| Employer ID | 27-1967997 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Sean O'Connor Ph.D. | Senior Vice President and President and Chief Executive Officer of Nucelis |
| Dr. Peter R. Beetham B.Sc., Ph.D. | Co-Founder, Interim Chief Executive Officer, President, Chief Operating Officer and Director |
| Rory Balfour Riggs M.B.A. | Co-Founder and Chairman |
| Cornelis Broos M.Sc. | Interim Chief Financial Officer |
| Dr. Gregory F. Gocal Ph.D. | Co-Founder, Chief Scientific Officer and Executive Vice President |
| Jason Stokes J.D. | Chief Legal Officer, General Counsel and Corporate Secretary |
| Rosa Cheuk Kim J.D. | Senior Vice President of Legal |
| Dr. James Radtke Ph.D. | Senior Vice President of Product Development |
| Tony Moran | Senior Vice President of International Development |
| Noel Sauer Ph.D. | Senior Vice President of Research |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 23, 2025 | 8-K | Current Report |
| Jun 10, 2025 | SCHEDULE 13D/A | Filing |
| Jun 6, 2025 | 8-K | Current Report |
| Jun 6, 2025 | 424B5 | Filing |
| Jun 4, 2025 | 8-K | Current Report |
| Jun 4, 2025 | 424B5 | Filing |
| May 27, 2025 | 8-K | Current Report |
| May 23, 2025 | 8-K | Current Report |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 8, 2025 | 10-Q | Quarterly Report |